Open Government Portal
The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List …
The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the …
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada …
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on …
The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List …
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones …
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada …
The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription …
A Notice of Compliance is a notification, issued pursuant to paragraph C.08.004(1)(a), indicating that a manufacturer has complied with sections …
The award-winning Health Infobase, a sub-domain of Canada.ca, provides Canadian health information on a wide variety of topics including …